Get the Stockscreener App
2.83
23.31%
-0.86
Pre-market:
2.84
0.010
+0.35%
Health Catalyst Inc stock is traded at $2.83, with a volume of 3.21M.
It is down -23.31% in the last 24 hours and down -29.95% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$3.69
Open:
$2.9
24h Volume:
3.21M
Relative Volume:
5.35
Market Cap:
$196.97M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-1.8867
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
-19.60%
1M Performance:
-29.95%
6M Performance:
-50.35%
1Y Performance:
-62.52%
1-Day Range:
$2.80
$3.2098
1-Week Range:
$2.80
$3.88
52-Week Range:
$2.80
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.83 | 265.88M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
282.13 | 46.19B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.87 | 9.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.58 | 10.89B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.05 | 7.86B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.59 | 5.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Wells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ Rating - MSN
Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price - uk.finance.yahoo.com
Slammed 30% Health Catalyst, Inc. (NASDAQ:HCAT) Screens Well Here But There Might Be A Catch - 富途牛牛
Health Catalyst Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Health Catalyst Q2 2025 Earnings Call Highlights: Revenue Exceeds Guidance, Restructuring Efforts Underway - AInvest
Health Catalyst Shares Fall After 2025 Revenue Guidance Cut, CEO to Step Down in June 2026 - 富途牛牛
Health Catalyst (HCAT): Navigating Medicaid Cuts and Strategic Restructuring to Unlock Long-Term Value - AInvest
Health Catalyst HCAT Stock Drops 21.5% on Weak Revenue GuidanceNews and Statistics - IndexBox
Why Health Catalyst (HCAT) Stock Is Down Today - Yahoo Finance
Health Catalyst's Leadership Transition and Financial Outlook: Navigating Short-Term Volatility for Long-Term Resilience - AInvest
Health Catalyst tanks after FY revenue outlook cut, Cantor downgrade - Seeking Alpha
Earnings call transcript: Health Catalyst Q2 2025 results show significant EPS miss - Investing.com
Health Catalyst stock downgraded by Cantor Fitzgerald amid revenue concerns - Investing.com Nigeria
Health Catalyst Inc (HCAT) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Funding ... - Yahoo Finance
Health Catalyst Reports Strong Q2 2025 Results - TipRanks
Health Catalyst Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Health Catalyst, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Health Catalyst: Q2 Earnings Snapshot - San Antonio Express-News
Longtime Health Catalyst CEO to step down - Modern Healthcare
Health Catalyst earnings missed by $0.63, revenue topped estimates - Investing.com Canada
Health Catalyst (NASDAQ:HCAT) Posts Q2 Sales In Line With Estimates But Stock Drops - TradingView
Health Catalyst CEO Dan Burton to step down effective June 2026 - TipRanks
Health Catalyst CEO Dan Burton to step down in June 2026 - Investing.com Australia
Health Catalyst reports Q2 adjusted EPS 4c, consensus 4c - TipRanks
Health Catalyst CEO Retirement Announcement - TipRanks
Health Catalyst CEO Exits at Peak: 1,100 Clients, $2.2B in Healthcare Improvements - Stock Titan
Health Catalyst Reports Second Quarter 2025 Results - The Manila Times
Health Catalyst Financial Results Announcement: What to ExpectNews and Statistics - IndexBox
Health Catalyst (HCAT) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Health Catalyst HCAT 2025Q2 Earnings Preview Upside Potential with Projected Revenue Growth - AInvest
Unity, Domo, Five9, Health Catalyst, and Shopify Shares Skyrocket, What You Need To Know - MSN
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt? - simplywall.st
Why is Health Catalyst Inc. stock attracting strong analyst attentionFind the best stocks for sustainable growth - Jammu Links News
What analysts say about Health Catalyst Inc. stockUnlock your portfolio’s hidden potential - Jammu Links News
Is Health Catalyst Inc. stock overvalued or undervaluedCapitalize on fast-moving stock trends - Jammu Links News
Is Health Catalyst Inc. a growth stock or a value stockDiscover breakthrough stocks with expert help - Jammu Links News
How does Health Catalyst Inc. generate profit in a changing economySuperior trading gains - Jammu Links News
What are Health Catalyst Inc. company’s key revenue driversHigh-velocity capital appreciation - Jammu Links News
What are analysts’ price targets for Health Catalyst Inc. in the next 12 monthsFree Investment Community - Jammu Links News
What catalysts could drive Health Catalyst Inc. stock higher in 2025Maximize your returns with expert insights - Jammu Links News
What are the latest earnings results for Health Catalyst Inc.Superior risk-adjusted returns - Jammu Links News
Health Catalyst Announces Q2 2025 Operating Results and Conference Call for August 7, 2025 - AInvest
Screener Results Flag Health Catalyst Inc. as OversoldScalable Portfolio Growth Suggestions Released - beatles.ru
Volume Surge May Signal Institutional Interest in Health Catalyst Inc.Watchlist for Smart Swing Trading Updated - metal.it
New Product Launches: Will They Boost Health Catalyst Inc. Stock in 2025Consistent Income Focused Trade List Analyzed - metal.it
Why Health Catalyst Inc. stock attracts strong analyst attentionReal Trader Watchlist of Hot Stocks Released - beatles.ru
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.97%
6.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):